6 Documents disponibles écrits par cet auteur
Cet ouvrage inédit, édition française enrichie et réactualisée du fameux titre allemand « Hanf als Medizin », est le premier guide pratique traitant exclusivement des applications médicales du cannabis (ou chanvre) et de ses produits dérivés, au[...]
One main justification for today's war on cannabis is its possible detrimental effect on the mental healh and social wellbeing of adolescents. In this week's Lancet, John Macleod and colleagues show that the causal relation is less certain than [...]
ENGLISH : Dronabinol (delta9-tetrahydocannabinol, THC), the main source of the pharmacological effects caused by the use of cannabis, is an agonist to both the CB1 and the CB2 subtype of cannabinoid receptors. It is available on prescription i[...]
Purpose: The purpose of this paper is to give a review on the developments leading to the 2017 law on the medical use of cannabis and cannabinoids in Germany, and to present the major advances arising from this law for the supply of patients wit[...]
ENGLISH : The author first describes the history of medical use of cannabis and its revival in the 1990s. He then provides an overview of the legal situation and how this affects doctors and patients if cannabis is prescribed or recommended as[...]
A. HAZEKAMP ; M. A. WARE ; K. R. MULLER-VAHL ; D. ABRAMS ; F. GROTENHERMEN | 2013
Dans Journal of Psychoactive Drugs (Vol.45, n°3, July-August 2013) Article : PériodiqueCannabinoids, including tetrahydrocannabinol and cannabidiol, are the most important active constituents of the cannabis plant. Over recent years, cannabinoid-based medicines (CBMs) have become increasingly available to patients in many countrie[...]
Historique
